Robert: Canada approves COVID-19 vaccine for kids

Published on November 19th, 2021 @ 11:04 AM


Health Canada has given the thumbs up to Pfizer-BioNTech’s two-dose COVID-19 vaccine for children. 

“After a thorough and independent scientific review of the evidence, the Department has determined that the benefits of this vaccine for children between 5 and 11 years of age outweigh the risks,” Health Canada says.

“Health Canada has placed terms and conditions requiring Pfizer-BioNTech to continue providing information to Health Canada on the safety and efficacy of the vaccine in this younger age group. This will provide the Department with more data from ongoing studies and real-world use to ensure that the benefits of the vaccine continue to outweigh any risks, as well as to detect any potential new safety signals in any age group.”

The vaccine will require two doses of 10 mcg for kids aged five to eleven, which is one third of the dose for adults. The plan is to give those two doses 21 days apart.

According to Pfizer’s clinical trial data, the vaccine has a 91% efficacy against COVID-19 in this age group.




Current track